Haleon (HLN) Profit After Tax (2021 - 2025)

Haleon's (HLN) quarterly Profit After Tax came in at $1.1 billion in Q4 2025, up 20.22% on a QoQ basis from $906.0 million in Q4 2023.

Haleon (HLN) Profit After Tax (2021 - 2025) Analysis & Trends

Haleon (HLN) has 4 years of Profit After Tax data on file, last reported at $1.1 billion in Q4 2025.

Quarterly Profit After Tax changed N/A year-over-year to $1.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.9 billion (changed N/A YoY) and the FY2025 annual result came in at $2.2 billion, up 18.52% from the prior year.
Profit After Tax grew to $1.1 billion in Q4 2025, from $906.0 million in the prior quarter.
In the past five years, Profit After Tax ranged from a high of $1.2 billion in Q4 2021 to a low of $394.2 million in Q2 2023.
A 4-year average of $835.6 million and a median of $906.0 million in 2023 frame the typical range for Profit After Tax.
Annual changes were most pronounced in 2022 — Profit After Tax retreated 12.31% — and 2023, when it decreased 15.02%.
Tracing HLN's Profit After Tax over 4 years: stood at $1.2 billion in 2021, then dropped by 12.31% to $1.1 billion in 2022, then slipped by 15.02% to $906.0 million in 2023, then rose by 20.22% to $1.1 billion in 2025.
The last three Profit After Tax figures came in at $1.1 billion (Q4 2025), $906.0 million (Q4 2023), and $394.2 million (Q2 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	PAT (Qtr)
1	Haleon	43.76 Bn	42.79 Bn	-	-
2	Teva Pharmaceutical Industries	43.38 Bn	39.73 Bn	2.15 Bn	-576.00 Mn
3	Zoetis	31.61 Bn	29.93 Bn	1.05 Bn	866.00 Mn
4	Takeda Pharmaceutical	28.64 Bn	22.84 Bn	5.10 Bn	710.56 Mn
5	United Therapeutics	22.20 Bn	19.54 Bn	683.80 Mn	333.00 Mn
6	Viatris	18.82 Bn	17.93 Bn	1.46 Bn	-118.80 Mn
7	Neurocrine Biosciences	15.67 Bn	15.28 Bn	935.80 Mn	149.10 Mn
8	Elanco Animal Health	12.11 Bn	11.58 Bn	798.00 Mn	54.00 Mn
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-	-
10	Alkermes	8.21 Bn	7.55 Bn	397.90 Mn	501,000.00

Download Data